Ginolis delivers first lateral flow device assembly (LFDA-3) system to China

Thursday, November 10, 2016 by Ginolis

Ginolis Ltd, a global desktop automation and liquid handling solutions provider, today announced the delivery of the first LFDA-3 to Suzhou Dingshi Medical Technology company in China. The revolutionary rapid test assembly solution provides manufacturers flexible production capacity within a desktop footprint.

"The new modular compact LFDA-3 went beyond all our expectations. We are very happy with the system and the cooperation with Ginolis ." states Dingshi CEO Alex Xi. "They have been professional and accommodated all our needs. We are looking forward to going further with Ginolis."

The innovative lateral flow device assembly solution provides high volume production capacity with automated visual inspection and guidance ensuring the highest standard of quality control. The LFDA-3 solution is easily adaptable and can assemble different rapid tests with minimal product specific adjustments.

"The first LFDA-3 system delivery was a great success. Dingshi has been a great partner and we look forward working with them in the future" states VP Sales and Marketing, Jorma Venäläinen. "This is a very important step for us moving forward in the Asia Pacific market. We feel that there is huge growth potential for Ginolis ' solutions in Asia and this deal is a testament to that."

The total value of the deal is not disclosed.

The company will be showcasing the LFDA-3 at the Medica tradeshow in Düsseldorf, Germany on November 14-17, 2016. Visit Ginolis Ltd at Hall 1 stand B15.


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.